Trial Profile
Intradermal Trivalent Influenza Vaccine in Young Adults, a Double-blind Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Influenza virus vaccine; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 04 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 25 Jun 2014 New trial record